GA
BCR

Geneva Advisors’s CR Bard Inc. BCR Stock Holding History

Geneva Advisors’s Portfolio BCR Stock Details BCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$251K Buy
+794
New +$236K ﹤0.01% 637

Other funds holding BCR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACPU
Arrowgrass Capital Partners (US) Dover, Delaware $380M AUM 20.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geneva Advisors's BCR Position: Q2 2017 in Review

Geneva Advisors opened a new position in CR Bard Inc. (BCR) in Q2 2017: 794 shares worth $251K. The stake represents ﹤0.01% of the portfolio and ranks #637 among its holdings.

675 funds tracked by Wall St. Rank hold BCR as of Q2 2017.

  • Geneva Advisors held 794 shares of CR Bard Inc. worth $251K as of Q2 2017.
  • CR Bard Inc. was a new Geneva Advisors position in Q2 2017.
  • CR Bard Inc. made up ﹤0.01% of Geneva Advisors's portfolio in Q2 2017, its #637 holding.
  • 675 funds tracked by Wall St. Rank held CR Bard Inc. as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.